Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Correlation of Serum IL-18, BDNF, and IL-1 β with Depression and Prognosis after Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • المؤلفون: Zhao N;Zhao N; Dong C; Dong C
  • المصدر:
    Computational and mathematical methods in medicine [Comput Math Methods Med] 2022 Apr 30; Vol. 2022, pp. 3555982. Date of Electronic Publication: 2022 Apr 30 (Print Publication: 2022).
  • نوع النشر :
    Journal Article; Retracted Publication
  • اللغة:
    English
  • معلومة اضافية
    • المصدر:
      Publisher: Hindawi Country of Publication: United States NLM ID: 101277751 Publication Model: eCollection Cited Medium: Internet ISSN: 1748-6718 (Electronic) Linking ISSN: 1748670X NLM ISO Abbreviation: Comput Math Methods Med Subsets: MEDLINE
    • بيانات النشر:
      Publication: 2011- : New York : Hindawi
      Original Publication: London : Taylor & Francis, c2006-
    • الموضوع:
    • نبذة مختصرة :
      Objective: To explore the correlation of serum IL-18, BDNF, and IL-1 β with depression and prognosis after acute exacerbation of chronic obstructive pulmonary disease (COPD).
      Methods: By means of retrospective analysis, the data of 240 patients at the acute exacerbation of COPD treated in our hospital (February 2018-February 2021) were analyzed. All patients received conventional treatment 1 d after admission, patients' serological indicators were measured before treatment, and after 30 d of follow-up, the patients were divided into the survival group (SG) and death group (DG) according to their clinical outcomes, the Beck's Depression Inventory (BDI) scores of the surviving patients were investigated, the correlation of IL-18, BDNF, and IL-1 β levels with depression was analyzed by R analytics, and the correlation of IL-18, BDNF, and IL-1 β levels with prognosis was analyzed by ROC curve analysis.
      Results: The results of 30 d follow-up showed that 220 patients survived (91.7%) and 20 patients died (8.3%). Among the surviving patients, 95 patients had depression and 125 patients did not have depression; the BDI scores of the depressed subjects and the nondepressed subjects were 10.35 ± 1.25 points and 2.06 ± 0.76 points, respectively; significant differences in IL-18, BDNF, and IL-1 β levels between SG and DG were observed ( P < 0.05); significant differences in IL-18, BDNF, and IL-1 β levels between the depressed subjects and the nondepressed subjects were observed (538.43 ± 19.02 vs. 515.32 ± 9.65, 7.54 ± 0.56 vs. 12.11 ± 2.41, and 8.70 ± 0.98 vs. 8.12 ± 0.87; P < 0.001); among the depressed patients, the IL-18 and IL-1 β levels were positively correlative with the BDI scores ( r = 0.781, r = 0.2583, P < 0.001, P = 0.012), and the BDNF level was negatively correlative with the BDI scores ( r = -0.3277, P = 0.001) before treatment; according to the ROC analysis, the AUC (95% CI) of IL-18, BDNF, and IL-1 β in predicting prognosis was 0.8770 (0.8281-0.9260), 0.7723 (0.6879-0.8567), and 0.7165 (0.6080-0.8250) ( P < 0.05), respectively.
      Conclusion: In regard to the depression in COPD patients after acute exacerbation, IL18 and IL-1 β show positive correlation, and BDNF presents negative correlation. All three indicators have predictive value for patient outcome.
      Competing Interests: The authors have no conflicts of interest to declare.
      (Copyright © 2022 Nan Zhao and Chengcheng Dong.)
    • Comments:
      Retraction in: Comput Math Methods Med. 2022 Dec 4;2022:9893716. (PMID: 36514694)
    • References:
      Int J Chron Obstruct Pulmon Dis. 2019 Jun 28;14:1343-1353. (PMID: 31388297)
      Expert Rev Pharmacoecon Outcomes Res. 2019 Jun;19(3):331-340. (PMID: 30324818)
      Gen Hosp Psychiatry. 2020 May - Jun;64:72-79. (PMID: 32279024)
      Eur J Pharmacol. 2019 Nov 5;862:172640. (PMID: 31491407)
      COPD. 2019 Dec;16(5-6):406-417. (PMID: 31638445)
      Clin Respir J. 2020 Oct;14(10):891-900. (PMID: 32510764)
      COPD. 2021 Apr;18(2):254-263. (PMID: 33709848)
      Ann Am Thorac Soc. 2021 Mar;18(3):442-451. (PMID: 33306930)
      J Affect Disord. 2021 Feb 15;281:147-152. (PMID: 33333473)
      Monaldi Arch Chest Dis. 2018 Mar 19;88(1):902. (PMID: 29557571)
      Aging Male. 2020 Dec;23(5):648-654. (PMID: 30739540)
      Int J Chron Obstruct Pulmon Dis. 2020 Dec 30;15:3417-3422. (PMID: 33408471)
      COPD. 2019 Aug;16(3-4):254-260. (PMID: 31298042)
      BMC Pulm Med. 2021 Jan 6;21(1):8. (PMID: 33407325)
      J Clin Nurs. 2019 Oct;28(19-20):3632-3640. (PMID: 31192478)
      PLoS One. 2018 Jun 11;13(6):e0197342. (PMID: 29889828)
      J Affect Disord. 2019 Jun 15;253:277-284. (PMID: 31071545)
      JAMA. 2013 Nov 27;310(20):2191-4. (PMID: 24141714)
      Trials. 2021 Jul 26;22(1):495. (PMID: 34311766)
      J Fam Pract. 2018 Feb;67(2 Suppl):S11-S18. (PMID: 29443332)
      Trials. 2020 Oct 15;21(1):858. (PMID: 33059755)
      Rev Esp Quimioter. 2020 Feb;33(1):49-67. (PMID: 31933347)
      J Gen Intern Med. 2008 Nov;23(11):1757-62. (PMID: 18690488)
      Sci Rep. 2019 Dec 27;9(1):20252. (PMID: 31882715)
      Trials. 2021 Apr 6;22(1):252. (PMID: 33823935)
    • الرقم المعرف:
      0 (Brain-Derived Neurotrophic Factor)
      0 (IL18 protein, human)
      0 (IL1B protein, human)
      0 (Interleukin-18)
      0 (Interleukin-1beta)
      7171WSG8A2 (BDNF protein, human)
    • الموضوع:
      Date Created: 20220510 Date Completed: 20220511 Latest Revision: 20231105
    • الموضوع:
      20231105
    • الرقم المعرف:
      PMC9078809
    • الرقم المعرف:
      10.1155/2022/3555982
    • الرقم المعرف:
      35535228